Jessica Parsons

Jessica Parsons, Ph.D. has extensive experience in scientific communications and clinical development. Jessica is currently an Associate Director at Inari Medical, leading the strategy and execution of scientific communications for the company's endovascular device portfolio. Their role includes generating clinical evidence, leading publication development, and analyzing data from clinical studies.

Prior to their current role, Jessica worked at Philips as an Associate Director and Senior Manager in Clinical Development. Jessica was responsible for driving the clinical evidence strategy across the Ultrasound Business product portfolio, designing clinical trials, and ensuring valid interpretation of evidence generated for claims validation, academic collaborations, publications, and regulatory submissions.

Before joining Philips, Jessica worked at Mirabilis Medical, Inc., a venture-funded start-up. Jessica served as a Clinical Science Lead, leading the design, conduct, data analysis, and reporting of clinical and preclinical studies for a high-intensity focused ultrasound (HIFU) tissue ablation device. Jessica also managed clinical science and results reporting for publications and pre-market filings with regulatory authorities.

Jessica's career started at the University of Michigan, where they worked as a Whitaker Foundation Graduate Research Fellow. Their research focused on medical ultrasound, particularly HIFU systems for noninvasive tissue ablation applications. Jessica was an early developer of cavitation-based histotripsy techniques.

Overall, Jessica Parsons has a strong background in scientific communications, clinical development, and medical ultrasound, with expertise in HIFU technology.

Jessica Parsons, Ph.D. has an extensive education history in the field of Biomedical Engineering. Jessica obtained their Bachelor of Science degree (summa cum laude) from Boston University. Following this, they pursued their Master of Science degree at the University of Michigan. Jessica then furthered their education at the University of Michigan, where they earned their Ph.D. in Biomedical Engineering. Recently, in 2021 to 2022, they attended Stanford University School of Medicine to complete a Professional Certificate in the Medical Statistics Program.